6 results in Exploration of Drug Science
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Case Report
Single or multiple treatments with lusutrombopag in subjects with thrombocytopenia and chronic liver disease needing an invasive procedure
Davide Scalabrini ... Pietro Andreone
Published: August 30, 2023 Explor Drug Sci. 2023;1:292–298
This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
Open Access
Commentary
Could flavonoid aglycones prevent the absorption of flavonoid glycosides by inhibiting sodium-dependent glucose transporter-1 in the small intestine?
Katrin Sak
Published: August 30, 2023 Explor Drug Sci. 2023;1:287–291
Open Access
Original Article
In silico study about β-amyloid’s role in Alzheimer’s disease and glaucoma and prediction of its interactions with glaucoma related proteins
Nancy Maurya
Published: August 29, 2023 Explor Drug Sci. 2023;1:276–286
This article belongs to the special issue Machine Learning for Drug Science
Open Access
Review
Natural compounds from medicinal plants against COVID-19
Anton Kolodnitsky ... Vladimir Poroikov
Published: August 28, 2023 Explor Drug Sci. 2023;1:253–275
This article belongs to the special issue Exploring Potential Drugs from Natural Products
Open Access
Review
Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes
Amedeo Lonardo
Published: August 28, 2023 Explor Drug Sci. 2023;1:239–252
Open Access
Review
The protective role of GLP-1 in neuro-ophthalmology
Sohum Sheth ... Brandon Lucke-Wold
Published: August 28, 2023 Explor Drug Sci. 2023;1:221–238
Journal Information